Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -16.849% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a COc1ccc(-c2nc3ccccc3c(=O)n2CCCN2CCOCC2)cc1
b COc1ccc(C(CNC(=O)CSc2ccc(Br)cc2C)N2CCOCC2)cc1
c COc1cccc(/C=N/NC(=O)CSc2ccccc2C)c1O
d O=C1CSC(=S)N1/N=C/c1c(F)cccc1F
Answer: c. COc1cccc(/C=N/NC(=O)CSc2ccccc2C)c1O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(/C=N/NC(=O)CSc2ccccc2C)c1O
COc1cccc(/C=N/NC(=O)CSc2ccccc2C)c1O
N-[(E)-(2-hydroxy-3-methoxyphenyl)methylideneamino]-2-(2-methylphenyl)sulfanylacetamide